𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reversible factors in portal hypertension

✍ Scribed by MASSIMO PINZANI; FRANCESCO VIZZUTTI

Book ID
108950091
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
42 KB
Volume
19
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reversal of portal hypertension and hype
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
✍ Mercedes Fernandez; Marc Mejias; Ester Garcia-Pras; Raul Mendez; Juan Carlos Gar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 678 KB

Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) pathways are crucial to angiogenesis, a process that contributes significantly to the pathogenesis of portal hypertension. This study determined the effects of inhibition of VEGF and/or PDGF signaling on hyperdynamic

Haematemesis in portal hypertension
Haematemesis in portal hypertension
✍ Sheila Sherlock πŸ“‚ Article πŸ“… 1964 πŸ› John Wiley and Sons 🌐 English βš– 448 KB
Metoprolol in portal hypertension
Metoprolol in portal hypertension
✍ BΓΌtzow, Gerd H. ;Remmecke, Jochen ;BrΓ€uer, Andrea πŸ“‚ Article πŸ“… 1982 πŸ› Springer-Verlag 🌐 English βš– 406 KB
Vasopressin reverses mesenteric hyperemi
Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats
✍ Akos Heinemann; Christof H. Wachter; Peter Fickert; Michael Trauner; Dr. Rudolf πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

We recently reported that vasopressin analogues correct the in vitro vascular hyporeactivity to adrenergic vasoconstrictors in portal hypertensive rats. The aim of the present study was to determine whether vasopressin reduces splanchnic blood flow in portal vein-ligated (PVL) rats by restoring vaso